Ann: SleepCheck Launched on Select Android Devices, page-128

Well said. Huge red flag to drift from the core business but w/ a track record or zero commercialisation & FDA rejection I guess they're just taking jump shots from behind mid-court now. Sure, will look spectacular if they hit the shot but we all know there's about 2% chance.

Would be surprised if they don't CR before the quarterly. Unless of course they've doubled revenue to 14k with only $2m spend to achieve it.